BRYANS JUSTIN STEPHEN

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl;R represents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; R represents …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof , wherein: Het represents 2-pyridinyl or 2-pyrimidinylR1 representsH,C1-3 alk yl or a nitrogen-containing heterocyclic ring having5 or 6 ring atoms R2 represents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof , wherein: Het represents 2-pyridinyl or 2-pyrimidinylR1 representsH,C1-3 alk yl or a nitrogen-containing heterocyclic ring having5 or 6 ring atoms R2 represents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof , wherein: Het represents 2-pyridinyl or 2-pyrimidinylR1 representsH,C1-3 alk yl or a nitrogen-containing heterocyclic ring having5 or 6 ring atoms R2 represents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl;R represents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; R represents …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl;R represents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; R represents …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl;R represents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; R represents …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof , wherein: Het represents 2-pyridinyl or 2-pyrimidinylR1 representsH,C1-3 alk yl or a nitrogen-containing heterocyclic ring having5 or 6 ring atoms R2 represents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof , wherein: Het represents 2-pyridinyl or 2-pyrimidinylR1 representsH,C1-3 alk yl or a nitrogen-containing heterocyclic ring having5 or 6 ring atoms R2 represents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof , wherein: Het represents 2-pyridinyl or 2-pyrimidinylR1 representsH,C1-3 alk yl or a nitrogen-containing heterocyclic ring having5 or 6 ring atoms R2 represents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl;R represents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; R represents …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl;R represents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; R represents …